Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study
We tested the prognostic impact of a marker of arterial stiffness, pulse pressure/stroke volume index (PP/SVi), in patients with hypertension and left ventricular (LV) hypertrophy. We used data from 866 patients randomized to losartan or atenolol-based antihypertensive treatment, over a median of 4....
Main Authors: | Costantino Mancusi, Eva Gerdts, Giovanni de Simone, Helga Midtbø, Mai Tone Lønnebakken, Kurt Boman, Kristian Wachtell, Björn Dahlöf, Richard B. Devereux |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-05-01
|
Series: | Blood Pressure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08037051.2016.1243009 |
Similar Items
-
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)
by: Mai Tone Lønnebakken, et al.
Published: (2017-03-01) -
Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study)
by: Costantino Mancusi, et al.
Published: (2021-04-01) -
On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy
by: Peter M. Okin, et al.
Published: (2020-09-01) -
Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study
by: Marcello Chinali, et al.
Published: (2022-04-01) -
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy–Application of A New Multivariate Predictive Model. The Life Study
by: Alexander Lilja-Cyron, et al.
Published: (2022-03-01)